Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.67 |
| ▸ | LMNA | P02545 | 2/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.57 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.50 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.50 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | RECQL | P46063 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | FNTA | P49354 | 1/20 | 0.43 |
| ▸ | FNTB | P49356 | 1/20 | 0.43 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | POLA1 | P09884 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4758469 | 1.00 | TSHR (0.67) | TSHRLMNAALDH1A1GPR84FFAR1 | |
| SCHEMBL4757158 | 1.00 | TSHR (0.67) | TSHRLMNAALDH1A1GPR84FFAR1 | |
| SCHEMBL1277943 | 1.00 | TSHR (0.67) | TSHRLMNAALDH1A1GPR84FFAR1 | |
| SCHEMBL4758137 | 1.00 | TSHR (0.67) | TSHRLMNAALDH1A1GPR84FFAR1 | |
| SCHEMBL1199597 | 1.00 | TSHR (0.67) | TSHRLMNAALDH1A1GPR84FFAR1 | |
| SCHEMBL1976107 | 1.00 | TSHR (0.67) | TSHRLMNAALDH1A1GPR84FFAR1 | |
| SCHEMBL1886420 | 1.00 | TSHR (0.67) | TSHRLMNAALDH1A1GPR84FFAR1 | |
| SCHEMBL816422 | 1.00 | TSHR (0.67) | TSHRLMNAALDH1A1GPR84FFAR1 | |
| SCHEMBL1245383 | 1.00 | TSHR (0.67) | TSHRLMNAALDH1A1GPR84FFAR1 | |
| SCHEMBL4758409 | 1.00 | TSHR (0.67) | TSHRLMNAALDH1A1GPR84FFAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119463536-A | Carbon material, preparation method, water-based conductive coating and carbon-coated aluminum foil | 广州慧谷新材料科技股份有限公司 | 2025-02-18 | — | — | CN | claimed |
| CN-115784881-A | Preparation method of vegetable oil polyalcohol and application of vegetable oil polyalcohol in polyurethane anticorrosive paint | 张家港市飞航科技有限公司 | 2023-03-14 | — | — | CN | claimed |
| US-12595495-B2 | Methods of producing omega-hydroxylated fatty acid derivatives | GENOMATICA, INC. (US) | 2026-04-07 | — | — | US | disclosed |
| US-20250288683-A1 | TETRAHYDROISOQUINOLINE HETEROBIFUNCTIONAL BCL-XL DEGRADERS | Treeline Biosciences, Inc. | 2025-09-18 | — | — | US | disclosed |
| EP-4519272-A1 | TETRAHYDROISOQUINOLINE HETEROBIFUNCTIONAL BCL-XL DEGRADERS | Treeline Biosciences, Inc. (US) | 2025-03-12 | — | — | EP | disclosed |
| CN-119463536-A | Carbon material, preparation method, water-based conductive coating and carbon-coated aluminum foil | 广州慧谷新材料科技股份有限公司 | 2025-02-18 | — | — | CN | disclosed |
| US-20250019731-A1 | Methods Of Producing Omega-Hydroxylated Fatty Acid Derivatives | AGAIN BIO APS (DK) | 2025-01-16 | — | — | US | disclosed |
| CN-118460487-A | Process for producing OMEGA-hydroxylated fatty acid derivatives | 基因组股份公司 | 2024-08-09 | — | — | CN | disclosed |
| CN-118374462-A | Process for producing OMEGA-hydroxylated fatty acid derivatives | 基因组股份公司 | 2024-07-23 | — | — | CN | disclosed |
| CN-105378486-B | Process for producing OMEGA-hydroxylated fatty acid derivatives | 基因组股份公司 | 2024-05-14 | — | — | CN | disclosed |
| US-11981952-B2 | Methods of producing omega-hydroxylated fatty acid derivatives | GENOMATICA, INC. (US) | 2024-05-14 | — | — | US | disclosed |
| EP-2129662-A2 | C21-DEOXY ANSAMYCIN DERIVATIVES AS ANTITUMOR AGENTS | Biotica Technology Limited (GB) | 2009-12-09 | — | — | EP | disclosed |
| WO-2008104812-A2 | C21-DE0XY ANSAMYCIN DERIVATIVES AS ANTITUMOR AGENTS | BIOTICA TECHNOLOGY LIMITED (GB) | 2008-09-04 | — | — | WO | disclosed |
| US-20080199925-A1 | Method For Producing an Aqueous Polymer Dispersion | BASF AKTIENGESELLSCHAFT (DE) | 2008-08-21 | — | — | US | disclosed |
| EP-1891140-A1 | METHOD FOR PRODUCING AN AQUEOUS POLYMER DISPERSION | BASF Aktiengesellschaft (DE) | 2008-02-27 | — | — | EP | disclosed |
| WO-2006131479-A1 | METHOD FOR PRODUCING AN AQUEOUS POLYMER DISPERSION | BASF AKTIENGESELLSCHAFT (DE) | 2006-12-14 | — | — | WO | disclosed |
| EP-0885886-B1 | PYRIDINECARBOXAMIDE DERIVATIVES | NISSHIN SEIFUN GROUP INC (JP) | 2002-05-29 | — | — | EP | disclosed |
| US-5972943-A | N-(NITRIC ACID,C14-18 ALKYL ESTER)-6-(1-(OPTIONALLY 4-SUBSTITUTED PIPERAZINYL)) PYRIDINE-3-CARBOXAMIDES; METHOD OF SYNTHESIS; ADMINISTERING TO TREAT CEREBRAL EDEMA; NO HYPOTENSIVE SIDE EFFECT | NISSHIN FLOUR MILLING CO., LTD. (JP) | 1999-10-26 | — | — | US | disclosed |
| EP-0885886-A1 | NOVEL PYRIDINECARBOXAMIDE DERIVATIVES | Nisshin Flour Milling Co., Ltd. (JP) | 1998-12-23 | — | — | EP | disclosed |
| EP-0398132-A2 | Phosphorous compounds | F. HOFFMANN-LA ROCHE AG (CH) | 1990-11-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12595495-B2 | Methods of producing omega-hydroxylated fatty acid derivatives | CYP4F11, CYP2F1, CYP4Z1 | TSHR 1330/4885LMNA 3439/4885ALDH1A1 327/4885 |
| US-20250288683-A1 | TETRAHYDROISOQUINOLINE HETEROBIFUNCTIONAL BCL-XL DEGRADERS | BCL2L1, BCL2, BCL2L10 | TSHR 3777/4885LMNA 3184/4885ALDH1A1 2981/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.